Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,965 | -37,917 | -21,770 | -12,416 | -5,059 |
| Depreciation Amortization | 13 | 66 | 52 | 39 | 25 |
| Accounts receivable | 30 | 197 | 226 | 226 | 226 |
| Accounts payable and accrued liabilities | 125 | -2,378 | 2,862 | -980 | -322 |
| Other Working Capital | 316 | -2,729 | 2,906 | -659 | -53 |
| Other Operating Activity | 5,130 | 19,173 | 349 | 1,501 | 597 |
| Operating Cash Flow | $-3,351 | $-23,588 | $-15,375 | $-12,289 | $-4,586 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -18 | -18 | -12 | N/A |
| Investing Cash Flow | $N/A | $-18 | $-18 | $-12 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 72,804 | 70,188 | 39,529 | 21,657 |
| Other Financing Activity | 0 | -2,319 | -2,247 | -2 | 0 |
| Financing Cash Flow | $N/A | $70,485 | $67,941 | $39,527 | $21,657 |
| Exchange Rate Effect | 86 | 49 | 169 | 190 | -95 |
| Beginning Cash Position | 97,857 | 50,929 | 50,929 | 50,929 | 50,929 |
| End Cash Position | 94,592 | 97,857 | 103,646 | 78,345 | 67,905 |
| Net Cash Flow | $-3,265 | $46,928 | $52,717 | $27,416 | $16,976 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,351 | -23,588 | -15,375 | -12,289 | -4,586 |
| Capital Expenditure | N/A | -18 | -18 | -12 | N/A |
| Free Cash Flow | -3,351 | -23,606 | -15,393 | -12,301 | -4,586 |